These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3517191)

  • 41. Serogroup distribution and virulence characteristics of sorbitol-negative Escherichia coli from food and cattle stool.
    Manna SK; Manna C; Batabyal K; Das B; Golder D; Chattopadhyay S; Biswas BK
    J Appl Microbiol; 2010 Feb; 108(2):658-65. PubMed ID: 19796127
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Escherichia coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology.
    Tarr PI; Neill MA; Clausen CR; Watkins SL; Christie DL; Hickman RO
    J Infect Dis; 1990 Aug; 162(2):553-6. PubMed ID: 2197346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Relation between the isolation of strains of Escherichia coli O157:H7 and the presence of hemorrhagic colitis in children].
    Vázquez V; Arredondo M; Trujillo F; Cravioto A
    Bol Med Hosp Infant Mex; 1987 Aug; 44(8):442-7. PubMed ID: 3307811
    [No Abstract]   [Full Text] [Related]  

  • 44. A quantitative comparison of the faecal flora of patients with ulcerative colitis and that of normal persons.
    Cooke EM
    J Pathol Bacteriol; 1967 Oct; 94(2):439-44. PubMed ID: 4965244
    [No Abstract]   [Full Text] [Related]  

  • 45. A statewide outbreak of Escherichia coli O157:H7 infections in Washington State.
    Ostroff SM; Griffin PM; Tauxe RV; Shipman LD; Greene KD; Wells JG; Lewis JH; Blake PA; Kobayashi JM
    Am J Epidemiol; 1990 Aug; 132(2):239-47. PubMed ID: 2196790
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sorbitol-negative Escherichia coli O157 other than H7.
    Borczyk AA; Lior H; Thompson S
    J Infect; 1989 Mar; 18(2):198-9. PubMed ID: 2651530
    [No Abstract]   [Full Text] [Related]  

  • 47. Escherichia coli O157:H7 associated with human infections in the United Kingdom.
    Day NP; Scotland SM; Cheasty T; Rowe B
    Lancet; 1983 Apr; 1(8328):825. PubMed ID: 6132163
    [No Abstract]   [Full Text] [Related]  

  • 48. Haemorrhagic colitis in child after visit to farm visitor centre.
    Parry SM; Salmon RL; Willshaw GA; Cheasty T; Lund LJ; Wearden P; Quoraishi AH; Fitzgerald T
    Lancet; 1995 Aug; 346(8974):572. PubMed ID: 7658792
    [No Abstract]   [Full Text] [Related]  

  • 49. Hemorrhagic colitis caused by Escherichia coli O157:H7--unusual ultrasonographic and computed tomography findings.
    Preiksaitis HG; Pham DH
    Can Assoc Radiol J; 1992 Dec; 43(6):451-3. PubMed ID: 1450977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Difference in susceptibility of mice raised under barrier-sustained (SPF) or conventional conditions to infectious megaenteron.
    Itoh K; Maejima K; Ueda K; Fujiwara K
    Microbiol Immunol; 1979; 23(9):909-13. PubMed ID: 161344
    [No Abstract]   [Full Text] [Related]  

  • 51. Haemorrhagic colitis epidemic in Africa.
    Isaäcson M; Canter PH; Effler P; Arntzen L; Bomans P; Heenan R
    Lancet; 1993 Apr; 341(8850):961. PubMed ID: 8096294
    [No Abstract]   [Full Text] [Related]  

  • 52. Identification of enterotoxigenic Escherichia coli by serogrouping.
    Berry RJ; Bettelheim KA; Gracey M
    Lancet; 1982 May; 1(8281):1124-5. PubMed ID: 6122917
    [No Abstract]   [Full Text] [Related]  

  • 53. Haemorrhagic colitis epidemic in Africa.
    Bernardino L; Espirito Santo V; Santos RP
    Lancet; 1993 Aug; 342(8869):495-6. PubMed ID: 8102449
    [No Abstract]   [Full Text] [Related]  

  • 54. Statistical considerations in the sampling of Escherichia coli from intestinal sources for serotyping.
    Hedges AJ; Howe K; Linton AH
    J Appl Bacteriol; 1977 Oct; 43(2):271-80. PubMed ID: 338572
    [No Abstract]   [Full Text] [Related]  

  • 55. Escherichia coli in the faecal flora of man.
    Hartley CL; Clements HM; Linton KB
    J Appl Bacteriol; 1977 Oct; 43(2):261-9. PubMed ID: 338571
    [No Abstract]   [Full Text] [Related]  

  • 56. In vitro comparison of fluorescent antibody technique with culture and slide agglutination for the detection of enteropathogenic Escherichia coli.
    Freid MA; Hafermann DR; Lepper MH
    Am J Med Sci; 1966 Jul; 252(1):75-7. PubMed ID: 5328822
    [No Abstract]   [Full Text] [Related]  

  • 57. Proceedings: Ulcerative colitis and enterococci.
    van der Wiel-Korstanje JA
    Antonie Van Leeuwenhoek; 1974; 40(2):325. PubMed ID: 4545583
    [No Abstract]   [Full Text] [Related]  

  • 58. Modelling intestinal inflammation and infection using 'mini-gut' organoids.
    Li VSW
    Nat Rev Gastroenterol Hepatol; 2021 Feb; 18(2):89-90. PubMed ID: 33257835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Highly active fluorescent antibodies with differently colored fluorescence to 14 serotypes of Escherichia coli].
    Tikhomirova VG; Riabtseva VA; Gusarova TA
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jul; 50(7):108-11. PubMed ID: 4590979
    [No Abstract]   [Full Text] [Related]  

  • 60. Sorbitol-negative phenotype among enterohemorrhagic Escherichia coli strains of different serotypes and from different sources.
    Ojeda A; Prado V; Martinez J; Arellano C; Borczyk A; Johnson W; Lior H; Levine MM
    J Clin Microbiol; 1995 Aug; 33(8):2199-201. PubMed ID: 7559979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.